🇺🇸 FDA
Patent

US 10626087

Indoline and tetrahydroquinoline sulfonyl inhibitors of dimetalloenzymes and use of the same

granted A61KA61K45/06A61P

Quick answer

US patent 10626087 (Indoline and tetrahydroquinoline sulfonyl inhibitors of dimetalloenzymes and use of the same) held by The Board of Regents of the University of Texas System expires Mon Apr 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Apr 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K45/06, A61P, A61P31/04